Who Owns Polaryx Therapeutics Stock?
NASDAQ: PLYXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.98 -0.99%
Ownership breakdown
- Held by institutions
- 4.40%
- Held by insiders
- 69.92%
- Institutional holders
- 14
- Institutions 4.4%
- Insiders 69.9%
- Public and other 25.7%
Who owns Polaryx Therapeutics stock?
Institutional investors own about 4.4% of Polaryx Therapeutics's shares, spread across 14 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 69.92% of PLYX.
The largest institutional holders are Vanguard Capital Management LLC (3.33%), Geode Capital Management, LLC (0.34%) and Vanguard Fiduciary Trust Co (0.21%). Together, the top 10 institutions control 4.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PLYX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PLYX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 1.66M | 3.33% | -0.0% |
| Geode Capital Management, LLC | 171.00K | 0.34% | +0.2% |
| Vanguard Fiduciary Trust Co | 105.07K | 0.21% | +0.5% |
| HRT Financial LP | 82.09K | 0.16% | +100.0% |
| State Street Corporation | 58.10K | 0.12% | 0.0% |
| Blackrock Inc. | 41.01K | 0.08% | 0.0% |
| Jane Street Group, LLC | 31.44K | 0.06% | +100.0% |
| Northern Trust Corporation | 27.99K | 0.06% | 0.0% |
| Allworth Financial LP | 7.73K | 0.02% | +100.0% |
| Vanguard Global Advisers, LLC | 6.32K | 0.01% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PLYX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.47M | 2.95% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 142.03K | 0.28% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 65.47K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 28.65K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 26.45K | 0.05% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 25.97K | 0.05% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 21.86K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 19.61K | 0.04% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 865 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Polaryx Therapeutics?
Vanguard Capital Management LLC is the largest institutional shareholder of PLYX, owning 3.33% of shares outstanding (1.66M shares) as of its latest 13F filing.
What percentage of Polaryx Therapeutics is owned by institutions?
Institutions own about 4.4% of PLYX shares and 14.6% of the public float.
How much of Polaryx Therapeutics do insiders own?
Insiders, such as officers and directors, own about 69.92% of PLYX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.